Evidence map›Paper›PMID 37035270›Full record

ArticleRisk management and healthcare policy2023

Potential Factors of Primary Hospital Healthcare Professionals in Hindering the Abolition of Routine Skin Test for Cephalosporin: A Cross-Sectional Study.

Bo Li, Li Jiang, Ni Wu, Yao Chen, Zhi Xu, Fengcheng Xu, Heping Chen, Tianhu Liu

Open access · goldAbstract read
In one paragraph

Article in Risk management and healthcare policy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Bo LiClinical Pharmacy Department, The Third Affiliated Hospital of Chengdu Medical College, Pidu District People's Hospital, Chengdu, Sichuan, People's Republic of China.ORCID 0000-0002-7341-1092
Li JiangClinical Pharmacy Department, The Third Affiliated Hospital of Chengdu Medical College, Pidu District People's Hospital, Chengdu, Sichuan, People's Republic of China.
Ni WuClinical Pharmacy Department, The Third Affiliated Hospital of Chengdu Medical College, Pidu District People's Hospital, Chengdu, Sichuan, People's Republic of China.
Yao ChenClinical Pharmacy Department, The Third Affiliated Hospital of Chengdu Medical College, Pidu District People's Hospital, Chengdu, Sichuan, People's Republic of China.
Zhi XuDepartment of Respiratory and Critical Care Medicine, The Third Affiliated Hospital of Chengdu Medical College, Pidu District People's Hospital, Chengdu, Sichuan, People's Republic of China.
Fengcheng XuDrug Clinical Trial Management Center, The Third Affiliated Hospital of Chengdu Medical College, Pidu District People's Hospital, Chengdu, Sichuan, People's Republic of China.
Heping ChenClinical Pharmacy Department, The Third Affiliated Hospital of Chengdu Medical College, Pidu District People's Hospital, Chengdu, Sichuan, People's Republic of China.
Tianhu LiuDrug Clinical Trial Management Center, The Third Affiliated Hospital of Chengdu Medical College, Pidu District People's Hospital, Chengdu, Sichuan, People's Republic of China.
Chengdu Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In 2021, National Health Commission of the People's Republic of Chinese issued a document that no longer recommended the routine skin test for cephalosporin (RSTC). However, there is still resistance to the cancellation of RSTC in a primary hospital. The study aimed to explore the potential factors for hindering the abolition of the RSTC in a county-level hospital based on the PRECEDE model. Methods: The cross-sectional study was conducted on healthcare workers in the Pidu District People's Hospital, Chengdu, by online questionnaire from September 10 to September 25 in the 2021.The PRECEDE model was used to divide the potential factors of healthcare professionals in hindering the abolition of the RSTC into predisposing factors, enabling factors and reinforcing factors. Data were analyzed by ANOVA, Chi-square test, multiple linear and multiple logistic regression analysis. Results: We collected 605 respondents' valid questionnaires. 254 healthcare professionals were against cancellation of the RSTC, accounting for 41.98%. Multiple linear regression analysis showed that working for 6~10 years (β = 1.953, P = 0.024), medium (β = 1.995, P = 0.030) or senior (β = 4.003, P = 0.007) professional qualification, pharmacists (β = 3.830, P = 0.013) and working in surgical department (β= 4.462, P < 0.001) were significantly associated with higher score of predisposing factors, enabling factors, and reinforcing factors on abolition of RSTC. Furthermore, multiple logistic regression analysis showed that pharmacists (OR=3.113, 95% CI: 1.341-7.223, P=0.030), medium professional qualification (OR=1.272, 95% CI: 0.702-2.302, P=0.008), scores of predisposing factors (OR=1.335, 95% CI: 1.033-1.726, P=0.009), and scores of enabling factors (OR=1.208, 95% CI: 1.109-1.315, P<0.001) were independently associated with the positive anticipated behavior on the abolition of RSTC. While nurses (OR=0.516, 95% CI: 0.284-0.938, P<0.001) were independently associated with anticipated negative behavior. Conclusion: Pharmacists, medium professional qualification, and healthcare professionals with higher scores of predisposing and enabling factors were more likely to have a positive anticipated behavior on the abolition of RSTC, while nurses did not.

Indexed as

cephalosporincross-sectional studypotential factorsPRECEDE modelskin test

Identifiers

PMID37035270
PMCPMC10081666
OpenAlexW4362584795

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.